{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T18:11:04Z","timestamp":1778004664671,"version":"3.51.4"},"reference-count":15,"publisher":"European Respiratory Society (ERS)","issue":"2","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["BOUCHE19R0; GENTZS24P0"],"award-info":[{"award-number":["BOUCHE19R0; GENTZS24P0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK065988"],"award-info":[{"award-number":["P30DK065988"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL155261"],"award-info":[{"award-number":["HL155261"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"NIEHS","doi-asserted-by":"crossref","award":["P30 ES010126 CEHS"],"award-info":[{"award-number":["P30 ES010126 CEHS"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2026,1,12]]},"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1183\/23120541.01492-2025","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T12:35:22Z","timestamp":1769776522000},"page":"01492-2025","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The cystic fibrosis airway cytokine interleukin-1\u03b2 enhances cystic fibrosis transmembrane conductance regulator modulator efficacy"],"prefix":"10.1183","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9435-0321","authenticated-orcid":false,"given":"Martina","family":"Gentzsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Boyles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Minges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah M.","family":"Cholon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5247-7060","authenticated-orcid":false,"given":"Carla M.P.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"2026050510155845000_12.2.01492-2025.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32597-8"},{"key":"2026050510155845000_12.2.01492-2025.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"},{"key":"2026050510155845000_12.2.01492-2025.3","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1807120"},{"key":"2026050510155845000_12.2.01492-2025.4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01133-2018"},{"key":"2026050510155845000_12.2.01492-2025.5","doi-asserted-by":"crossref","first-page":"628722","DOI":"10.3389\/fphar.2021.628722","article-title":"Airway epithelial inflammation in vitro augments the rescue of mutant CFTR by current CFTR modulator therapies","volume":"12","author":"Gentzsch","year":"2021","journal-title":"Front Pharmacol"},{"key":"2026050510155845000_12.2.01492-2025.6","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.3390\/cells10113260","article-title":"Impact of airway inflammation on the efficacy of CFTR modulators","volume":"10","author":"Ribeiro","year":"2021","journal-title":"Cells"},{"key":"2026050510155845000_12.2.01492-2025.7","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00746-2023"},{"key":"2026050510155845000_12.2.01492-2025.8","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S2213-2600(24)00205-4","article-title":"Evaluation of elexacaftor-tezacaftor-ivacaftor treatment in individuals with cystic fibrosis and CFTR\n               N1303K in the USA: a prospective, multicentre, open-label, single-arm trial","volume":"12","author":"Solomon","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2026050510155845000_12.2.01492-2025.9","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(24)00305-9"},{"key":"2026050510155845000_12.2.01492-2025.10","doi-asserted-by":"crossref","first-page":"e150398","DOI":"10.1172\/JCI150398","article-title":"Inflammatory cytokines TNF-\u03b1 and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulators","volume":"131","author":"Rehman","year":"2021","journal-title":"J Clin Invest"},{"key":"2026050510155845000_12.2.01492-2025.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201706-1139oc"},{"key":"2026050510155845000_12.2.01492-2025.12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00408-025-00806-6","article-title":"The role of triple CFTR modulator therapy in reducing systemic inflammation in cystic fibrosis","volume":"203","author":"Garc\u00eda","year":"2025","journal-title":"Lung"},{"key":"2026050510155845000_12.2.01492-2025.13","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219943"},{"key":"2026050510155845000_12.2.01492-2025.14","doi-asserted-by":"crossref","first-page":"43430","DOI":"10.1038\/s41598-025-26263-y","article-title":"People with cystic fibrosis with high sputum neutrophil elastase on elexacaftor-tezacaftor-ivacaftor exhibit worse pulmonary function and pro-inflammatory airway milieu","volume":"15","author":"Cammarata-Mouchtouris","year":"2025","journal-title":"Sci Rep"},{"key":"2026050510155845000_12.2.01492-2025.15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00150-2025"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.01492-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:16:55Z","timestamp":1778001415000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.01492-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4,29]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1183\/23120541.01492-2025"],"URL":"https:\/\/doi.org\/10.1183\/23120541.01492-2025","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]}}}